Compare NEO & PMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NEO | PMT |
|---|---|---|
| Founded | 2001 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2008 | N/A |
| Metric | NEO | PMT |
|---|---|---|
| Price | $9.01 | $12.18 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 5 |
| Target Price | $11.14 | ★ $13.50 |
| AVG Volume (30 Days) | ★ 1.6M | 1.1M |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 13.22% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.63 | N/A |
| Revenue Next Year | $9.73 | $1.55 |
| P/E Ratio | ★ N/A | $12.59 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.72 | $11.15 |
| 52 Week High | $13.74 | $13.80 |
| Indicator | NEO | PMT |
|---|---|---|
| Relative Strength Index (RSI) | 59.44 | 57.66 |
| Support Level | $8.68 | $11.72 |
| Resistance Level | $10.82 | $12.76 |
| Average True Range (ATR) | 0.50 | 0.20 |
| MACD | 0.14 | 0.03 |
| Stochastic Oscillator | 95.00 | 90.54 |
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
PennyMac Mortgage Investment Trust is a specialty finance company that invests primarily in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.